Becaplermin: A Viewpoint by Vincent Falanga

Author： Falanga V.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.11, Iss.5, 1999-05, pp. : 366-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Becaplermin: A Viewpoint by David L. Steed

By Steed D.L.  

BioDrugs, Vol. 11, Iss. 5, 1999-05 ,pp. : 366-366

Adis International

Access to resources Recommend Favorite

Becaplermin

By Balfour J.A.B.   Noble S.  

BioDrugs, Vol. 11, Iss. 5, 1999-05 ,pp. : 359-364

Adis International

Access to resources Recommend Favorite

Etanercept: A Viewpoint by Muhammad A. Khan

By Khan M.A.  

BioDrugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 206-206

Adis International

Access to resources Recommend Favorite

Alefacept: A Viewpoint by Alice Gottlieb

By Gottlieb A.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 4, 2003-01 ,pp. : 287-287

Adis International

Access to resources Recommend Favorite

Imiquimod: A Viewpoint by John Geisse

By Geisse John  

American Journal of Clinical Dermatology, Vol. 6, Iss. 3, 2005-01 ,pp. : 201-201

Adis International

Access to resources Recommend Favorite